Investment giant Invesco has unveiled a Ucits-compliant Sicav fund.
The China Healthcare Equity fund aims to deliver long-term capital growth by investing in a concentrated portfolio of mid-cap stocks of Chinese healthcare companies with sustainable growth potential.
It will be run by senior fund manager Chris Liu in Hong Kong and made available to institutional and retail investors in the UK as well as authorised countries in Europe.
“We’ve launched our first China healthcare equity fund to embrace the take off of China’s healthcare sector,” said Chin Ping Chia, head of China A investments, business strategy and development at Invesco.
“The China healthcare sector has strong potential to expand due to robust growth in healthcare spending underpinned by a rise in wealth and an aging population, making healthcare a hugely important sector for China’s society and economy. An active approach to investing in the healthcare market will allow us to capture such opportunities.”
Andrew Lo, head of Asia Pacific at Invesco, added: “Invesco has been managing capabilities in China for nearly 30 years and has deep, on the ground expertise. By launching this fund, we are able to bring our local healthcare expertise to the global market and offer wider investment opportunities to our clients.
“As China’s CNY6.8trn (£756bn, $1trn, €878m) healthcare industry continues to expand, we foresee rising interest from global investors which makes the need for a China A-Shares healthcare fund greater than ever.”
